Loading insider details...
Latest Form 4 (Jun 4, 2026): Grant/Award of 35,000 TRVI shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Jun 4, 2026 | Trevi Therapeutics, Inc. (TRVI) | Grant/Award | 35,000 | n/a |
| Jun 13, 2025 | Trevi Therapeutics, Inc. (TRVI) | Grant/Award | 45,000 | n/a |
| Jun 14, 2024 | Trevi Therapeutics, Inc. (TRVI) | Grant/Award | 30,000 | n/a |
| Jun 30, 2023 | Trevi Therapeutics, Inc. (TRVI) | Grant/Award | 30,000 | n/a |
| Jun 23, 2022 | Trevi Therapeutics, Inc. (TRVI) | Grant/Award | 20,000 | n/a |
| Jun 17, 2021 | Trevi Therapeutics, Inc. (TRVI) | Grant/Award | 20,000 | n/a |
| Jun 15, 2020 | Trevi Therapeutics, Inc. (TRVI) | Grant/Award | 14,210 | n/a |